
JOB PU RP OSE 工 作 目 的
Su mmari zes t he jo b’s pu rp ose or r ole a nd w hy it ex ists in the or ga nizat ion
概 述 工 作 的 目 的 或 角 色 及 其 在 机 构 内 的 价 值
F ie ld-b ased p osit ion re sp on sib le for imp le me nta tion of act ivities for e sta blish me nt of scie nt ific lea der ship of AstraZen eca Th is in clu des d eve lop me nt and e nha nce me nt of pro fe ssio nal r ela tio nsh ips with hea lth care pro fe ssio na ls, b uilding de ep s cie ntific u nder sta nding of AstraZen eca co mp ou nd s D riving p osit ive o pin io ns for the scient ific a nd c lin ical value of AZ co mp ou nds for pat ients’ n eed s D eliver me dical e du ca tion and c linical su pp ort to me dical p ro fe ssio nals, tra in ing sales t ea ms a nd involve me nt in de ve lo pme nt of brand strat egy The p osition may also be in vo lved in r eview of pro du ct mat eria ls a nd re sp on se to me dical q ue rie s
Th ere are 4 levels in M SL te ch nical r ole, ie. MSL, Sr M SL, Exe cu tive M SL and Principle MSL
NATU RE & SCOPE 工 作 性 质 及 范 围
(a) Org anizat ion stru cture 组 织 机 构
(Ple ase at ta ched an u pd ated org an iza tion ch art of yo ur t eam 请 附 上 你 所 属 团 队 的 最 新 结 构 图)
Dep en ding on sp ecific te am stru cture
- Fu nct io na lly re ports to 功 能 汇 报
(P lease specify posit ion tit le 请 注 明 职 位 名 称)
Dep en ding on spe cif ic te am stru cture
- Operat io nally re ports to 运 作 汇 报
Dep en ding on spe cif ic te am stru cture
(b) Key wor king r ela tio nsh ips 主 要 工 作 关 系
- Int ernal cont acts with in AZ 内 部 联 系 Oth er M ed ical a ffa irs fu nct ion Com mer cial ( ie, Sa le s, M arket in g…) Evidence Generation
M arket Acce ss
Com plia nce
- Exter nal cont acts w ith org an iza tions o ut side AZ 外 界 联 系
KEE/HCP
Health Care Prof ession als
Stu dy In ve st igat ors
Pa yer Cu sto mers and Policy Ma kers
(c) Job re quire me nts
Esse nt ial
Aca dem ic / Pro fe ssio nal qu alif icat ion
· M aster ad va nced d eg ree in clinical / life science q ualif icat io n or 2+ year on r ele vant e xp erie nce of m edical af fairs in p ha rm aceut ical co mp any
· Ba ch elor de gree w ith stro ng med ical ba ckground or 4+ year relevant e xp erien ce of m ed ical af fairs in ph arma ce utical com pany
Te ch nical / s kill
· Kn owled ge a nd exp erie nce of the p har ma ceut ical in du stry a nd the area of f ie ld me dical liaiso ns
· Ab ility to int era ct and ma nage a ran ge of sta ke hold ers b oth in tern ally and e xtern ally
· Kn owled ge of le gislat ion r ele va nt to p harma ceut ical sales a nd m arke ting
· Se lf-m ana gem ent and exe cu tion ability
De sira ble
Und erst an ding of mu ltiple asp ects w it hin M edical L ia iso ns
Exp erie nce in trainin g co nsu lt ing
L ang uage ab ility 语 言 能 力
Flue nt in spo ke n w rit ten En glish
Com put er litera cy 电 脑 知 识
Flue nt M icro soft Of fice operat ion skills
Role a nd Resp onsi bility
O bje cti ves
C ritical a ctio ns
Meas ure me nts
Exte rnal Me dical & Scie nt if ic e nga ge me nt
Build, e nha nce and
mai nt ain the e ngag ement with scientific leader
· 60% of time in f ield e ngagi ng HCPs and exter nal st ake hol ders acro ss territ ory a nd bra nds
· Pr oac ti vely i dent ify HCPs with high l evels of sci ent ific ex perti se in l ocal tr ea tment practice to colla borate on spec ific medi cal mar keti ng ac ti viti es
· D evelo pment a nd impl ement ati on of KEE engag ement plan in c olla borati on with line ma nager. Review with line m anager t his plan
every quarter, develop KEE visit pla n- t his i ncl udes pre c all visit/e ng ag ement pl an with cl ear o bje cti ve of the visit, key poi nts di sc ussion for
t he vi sit, da ta to be s har ed and di sc ussed with
the KEE
· D evelop own sci enti fic k no wledge for disc ussion on all aspects of the data to be shared with KEE in a scie nti fic, o bje ct ive and bal anc ed way thr ough
11 di sc ussio ns Prep are for such i nteracti ons
with peer gro up di sc ussio ns R espo nd to unsolicited r equests for i nfo rma tion abo ut una ppr oved AZ pr oducts or una ppr oved uses of a ppr oved pr oduct s, pr esenti ng such i nforma tion in an obje cti ve, s cientif ically bal anc ed, subst anti ated ma nner. D evelop da ta base of Key external experts and al so pr ovide r eco mmenda tio ns for a dvi so ry board partici pa tion
Q ua nti ty
· 60% of avail able time spent meeti ng KEEs. (Available time = tota l da ys mi nus holid ays, w eeke nds, si ck ness)
· Complete records of KEE visits a nd r eg ular r evi ew by MSL line m anager (d efi ne ro uti ne review as mo nt hly for new st arters and quarterly for no n- new star ter s)
· Coverage/engagement of KEEs versus plan
· Impr ovement in advocacy s core
Q uali ty
· M eeti ng skil ls and pr esent ati on skills bas ed on in fi eld c oac hi ng and as sessment
· a nnual r ole play assessment of ca pa bilities and s cientif ic k no wl edg e– use st andard as sessment form and met ho dology
· Feedback from KEEs
Build a nd mai nt ain tr ust-
bas ed r ela tio nshi ps with
ext er nal st ake hol ders
· Build AZ r ela tio nship with key exter nal st ake hol ders (e. g pa ti ent a dvocacy gr oups, key medical orga niza tio ns, ho spi tal phar mac y). Fi nd o pport unities to c olla borate w ith such exter nal st ake hol ders Pr ovi de s cientif ic support in CME
events and thr ough appr opri ate m edical spo nsor shi ps part ner ship
· Act as sc ientif ic ex pert in the di sea se ar ea (s) by pr esenti ng thera peut ic upda tes to ex ter nal
st ake hol ders
· Q ua nti ty of CM Es and M edical
Spo nsor ship versus plan
· P ositi ve c ust omer feedback po st events
D evelop or i niti ate
sci ent ific pr ogra ms to ex plore unmet medical needs in priori ty di sease ar ea( s)
· W ork with HCPs in sci enti fic acti vit ies that help a dva nce di sea se under st andi ng such as
- I dentify a nd r ecommend KEEs for Advisory
Bo ar ds
- I dentify potenti al spea kers and train spea kers as appr opria te
- I nteract in the fi eld with the medical com munity in the c ontext of vario us medical pr oj ect s, such as cli nical tri al s, ESR s, s cientif ic ex cha nge meeti ngs
- Di sc uss potenti al i nvol vement in LCM
- R espo nd to unsolicited off l abel questi ons fr om KEEs
· A ble to c onduct bas ic di sc ussio ns on cli nical trials in terms of st udy design a nd feas ibility
Q ua nti ty
· No. of A dvi sory B oard M eeti ngs versus plan
· No. of P2P sro und table di sc ussio ns versus plan
· No. of CM Es ver sus plan
· No. of ESRs c ommunicated
Q uali ty
· Positive cu st omer feedback
· In fi eld observa tion by li ne m anager a nd c oac hi ng form
Me dical & S cie nti fic Support for i nt ernal s tak eholde rs
Act as sci entif ic exp ert in
priori ty di sea se ar ea (s) for i nter nal st ake hol ders
· Co nti nuo usly ac quire and upda te nec essary sci ent ific k no wledge on ther apeutic ar ea a nd r el eva nt compo unds
· Pr ovi de the AZ i nter nal st ake hol ders with an under st andi ng of the l ocal medical c ommunit y, cli nical practic e, tr ends and r eal or perc eived g aps in c urre nt sci ent ific k no wledge and m edical trea tment, c ompeti tor i nfor ma tion
· Pr ovi de r eg ular upda te on pa rt ner shi ps with HCP s, as spea ker s, or in the c ontext of m edical pr oj ects
· I niti ate and c onduct a ppr opr ia te AZ st aff trai ni ng &
develo pment on i nforma tion r egar di ng c urre nt a nd e mergi ng c li nical da ta a nd e mer gi ng tr ends in cli nical medici ne and practice wit hin TA
· To work with i nter nal cr oss functio nal team on form ulary li sti ng
· Pr ovi de sci ent ific support at AZ sp onsor ed educa tio nal events
Q ua nti ty
· % of trai ni ngs c onducted ver sus plan
· No of da ys pr ovi di ng trai ni ng versus plan
·
Q uali ty
· F eedback on trai ni ng from partici pa nts
· F eedback fr om busi ness part ners on quali ty of c ontri buti on to M edical a nd Br and pla ns – coll ected by li ne ma nager
Pe rso nal Dev elopme nt
Co nti nuo usly demo nstr ate develo pment of sci ent ific ex pert ise in di sea se ar ea( s) of c ompa ny foc us
· At tend r el eva nt sc ientif ic co ngr esses a nd HCP meeti ngs to g at her new kno wl edge on AZ compo unds, comp eti tor i nfo rma tion and t hera peutic ar ea
· P ositi ve e nga gement a nd r espo nse to c oac hi ng a nd f eedback r ec ei ved from l ine ma nage r
· In daily work ta kes ti me to r efl ect on c ust omer i nteracti ons and wor ks on ar eas agr eed with line ma nager as priori ties for develo pment. D evelop functio nal ca pa bility in the ro le
· Pr oac ti vely demo nstr ate the AZ Val ues
· I dentify ar eas for self-develo pment and di sc uss develo pment al needs with li ne ma nager usi ng the
70 -2 0-10 pri ncip le (ex peri ent ial l ear ni ng, co ac hi ng/ networ ki ng/ rela tio nshi p-ba sed lear ni ng a nd cla ssr oom tr ai ni ng). Acti ve partici pa tion in AZ tr ai ni ng, pr oje ct s, and m eeti ngs dependi ng on develo pm ent needs
Q uali ty
· 100% c ompl eti on of tr ai ni ng as r equir ed on M edical Ac ademy and AZLearn
· F eedback on c ongr ess r eport/ highlig hts shar ed with cro ss- functio nal team as pla nned – compl eted f eedback templa tes
· Has a per so nal develo pment plan a nd c ompl etes i dentif ied develo pment ac tiviti es as pl anned
C omplia nce
Complia nce with r el eva nt
compa ny and i ndustry co de of Co nduct a nd al so to c omply with l ocal co untry c odes
· K eep r eg ular upda te and opera te wit hin the r el eva nt Co des of Co nduct, Et hical I nteracti ons
(EI), i nclu di ng GP EI a nd SOPs
· Be su re to under st and AZ polici es when e nga ge to
KEEs and key external stakeholder.
· 100% adherence to c omplia nce
Date Posted
15-12月-2025
Closing Date
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com.
Community Guidelines: bit.ly/2MgAcio